Tg Therapeutics (TGTX) Change in Taxes (2025 - 2026)

Tg Therapeutics' (TGTX) quarterly Change in Taxes came in at -$6.7 million in Q1 2026, down 1746.57% year-on-year from $408000.0 in Q1 2025, and down 1746.57% quarter-over-quarter from $408000.0 in Q1 2025.

Tg Therapeutics (TGTX) Change in Taxes (2025 - 2026) Analysis & Trends

Tg Therapeutics' Change in Taxes history runs 2 years deep, the most recent figure standing at -$6.7 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -8,939.03
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Tg Therapeutics 8.08 Bn 8.00 Bn 171.41 Mn -6.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.72 Mn
Mar 31, 2026 -6.72 Mn
Mar 31, 2025 408,000.00
Mar 31, 2025 408,000.00